| Financial Year |
March 31 2023 |
| Monetary Funds |
827,128,300.24 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,850,050.80 |
| Accounts Receivable |
888,816,184.36 |
| Advances to Suppliers |
12,891,915.64 |
| Other Receivables |
32,404,925.07 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
133,868,635.84 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,341,264.82 |
| Total Current Assets |
2,010,667,412.33 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
153,235,092.35 |
| Under-construction Projects |
120,595,395.28 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
38,991,172.79 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,005,291.26 |
| Deferred Income Tax Assets |
37,154,106.77 |
| Other Non-Current Assets |
9,576,758.10 |
| Sub-Total of Non-Current Assets |
547,535,480.57 |
| Total Assets |
2,558,202,892.90 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
258,778,800.36 |
| Accounts Payable |
296,067,368.84 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,205,033.09 |
| Taxes Payable |
10,246,583.63 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,595,615.81 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,078,401.28 |
| Other Current Liabilities |
7,739,575.45 |
| Sub-Total of Current Liabilities |
647,250,324.19 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
21,981,480.68 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
42,621,446.67 |
| Total Liabilities |
689,871,770.86 |
| Paid-In Capital(Or Share Stock) |
160,000,000.00 |
| Capital Surplus |
686,707,445.44 |
| Surplus Reserve |
77,290,837.34 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
803,581,285.38 |
| Minority Stockholder's Interest |
7,749,991.52 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,860,581,130.52 |
| Owner's Equity（Stockholder's Equity） |
1,868,331,122.04 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,558,202,892.90 |
